Atlas Trials

Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer

Clinical trial NCT05896865 · RECRUITING

Trial details

NCT number
NCT05896865
Sponsor
Samsung Medical Center
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer Stage III
Start date
2023-03-16
Primary completion
2028-03-16
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.